Movement Disorders Caused by Medical Disease

ABSTRACT

Movement disorders often occur in the context of medical illness, whether as the presenting sign of the illness, as a related feature of the underlying disease process, or as a complication of treatment. Early recognition of an underlying medical cause for movement disorders is essential because the treatment and prognosis differ significantly depending on the underlying pathophysiology. Parkinsonism, nonparkinsonian tremor, dystonia, and chorea have a wide variety of etiologies, requiring a careful medical history in the evaluation of new-onset movement disorders. The spectrum of medical diseases associated with these four syndromes is reviewed in this article.

KEYWORDS

Systemic disease - parkinsonism - dystonia - chorea - tremor

REFERENCES

• 1 García-Moreno J M, Chacón-Peña J. Hypothyroidism and Parkinson's disease and the issue of diagnostic confusion.  Mov Disord. 2003;  18(9) 1058-1059
• 2 Kim H T, Edwards M J, Lakshmi Narsimhan R, Bhatia K P. Hyperthyroidism exaggerating parkinsonian tremor: a clinical lesson.  Parkinsonism Relat Disord. 2005;  11(5) 331-332
• 3 Li J Y, Yong T Y, Sebben R, Khoo E, Disney A P. Bilateral basal ganglia lesions in patients with end-stage diabetic nephropathy.  Nephrology. 2008;  13(1) 68-72
• 4 Lee P H, Shin D H, Kim J W, Song Y S, Kim H S. Parkinsonism with basal ganglia lesions in a patient with uremia: evidence of vasogenic edema.  Parkinsonism Relat Disord. 2006;  12(2) 93-96
• 5 Tambyah P A, Ong B K, Lee K O. Reversible parkinsonism and asymptomatic hypocalcemia with basal ganglia calcification from hypoparathyroidism 26 years after thyroid surgery.  Am J Med. 1993;  94(4) 444-445
• 6 Vaamonde J, Legarda I, Jimenez-Jimenez J, Zubieta J L, Obeso J A. Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism.  Mov Disord. 1993;  8(3) 398-400
• 7 Evans B K, Donley D K. Pseudohypoparathyroidism, parkinsonism syndrome, with no basal ganglia calcification.  J Neurol Neurosurg Psychiatry. 1988;  51(5) 709-713
• 8 Pearson D W, Durward W F, Fogelman I, Boyle I T, Beastall G. Pseudohypoparathyroidism presenting as severe Parkinsonism.  Postgrad Med J. 1981;  57(669) 445-447
• 9 Kovacs C S, Howse D C, Yendt E R. Reversible parkinsonism induced by hypercalcemia and primary hyperparathyroidism.  Arch Intern Med. 1993;  153(9) 1134-1136
• 10 Manyam B V. What is and what is not ‘Fahr's disease’.  Parkinsonism Relat Disord. 2005;  11(2) 73-80
• 11 Costello D J, Walsh S L, Harrington H J, Walsh C H. Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series.  J Neurol Neurosurg Psychiatry. 2004;  75(4) 631-633
• 12 Russo N, Edwards M, Andrews T, O'Brien M, Bhatia K P. Hereditary haemochromatosis is unlikely to cause movement disorders: a critical review.  J Neurol. 2004;  251(7) 849-852
• 13 Klos K J, Ahlskog J E, Josephs K A, Fealey R D, Cowl C T, Kumar N. Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity of magnetic resonance imaging: probable manganese toxicity.  Arch Neurol. 2005;  62(9) 1385-1390
• 14 Burkhard P R, Delavelle J, Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.  Arch Neurol. 2003;  60(4) 521-528
• 15 Shulman L M, Minagar A, Weiner W J. Reversal of parkinsonism following liver transplantation.  Neurology. 2003;  60(3) 519
• 16 Prevett M C, Rossor M N. Central pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis.  Mov Disord. 1999;  14(3) 523-525
• 17 Sedel F, Saudubray J M, Roze E, Agid Y, Vidailhet M. Movement disorders and inborn errors of metabolism in adults: a diagnostic approach.  J Inherit Metab Dis. 2008;  31(3) 308-318
• 18 Biegstraaten M, van Schaik I N, Aerts J M, Hollak C E. ‘Non-neuronopathic’ Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature.  J Inherit Metab Dis. 2008;  31(3) 337-349
• 19 Rogaeva E, Hardy J. Gaucher and Parkinson diseases: unexpectedly related.  Neurology. 2008;  70(24) 2272-2273
• 20 Evans A H, Costa D C, Gacinovic S et al.. L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: in vivo dopamine transporter and D2 receptor findings.  Mov Disord. 2004;  19(10) 1232-1236
• 21 Alarcón F, Gimenéz-Roldán S. Systemic diseases that cause movement disorders.  Parkinsonism Relat Disord. 2005;  11(1) 1-18
• 22 Tse W, Cersosimo M G, Gracies J M, Morgello S, Olanow C W, Koller W. Movement disorders and AIDS: a review.  Parkinsonism Relat Disord. 2004;  10(6) 323-334
• 23 Hersh B P, Rajendran P R, Battinelli D. Parkinsonism as the presenting manifestation of HIV infection: improvement on HAART.  Neurology. 2001;  56(2) 278-279
• 24 Walker R H, Spiera H, Brin M F, Olanow C W. Parkinsonism associated with Sjögren's syndrome: three cases and a review of the literature.  Mov Disord. 1999;  14(2) 262-268
• 25 Joseph F G, Lammie G A, Scolding N J. CNS lupus: a study of 41 patients.  Neurology. 2007;  69(7) 644-654
• 26 García-Moreno J M, Chacón J. Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature.  Mov Disord. 2002;  17(6) 1329-1335
• 27 Khubchandani R P, Viswanathan V, Desai J. Unusual neurologic manifestations (I): Parkinsonism in juvenile SLE.  Lupus. 2007;  16(8) 572-575
• 28 Kunas R C, McRae A, Kesselring J, Villiger P M. Antidopaminergic antibodies in a patient with a complex autoimmune disorder and rapidly progressing Parkinson's disease.  J Allergy Clin Immunol. 1995;  96(5 Pt 1) 688-690
• 29 Lee P H, Joo U S, Bang O Y, Seo C H. Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism.  Neurology. 2004;  63(2) 395-396
• 30 Huang Y C, Lyu R K, Chen S T, Chu Y C, Wu Y R. Parkinsonism in a patient with antiphospholipid syndrome: case report and literature review.  J Neurol Sci. 2008;  267(1–2) 166-169
• 31 Bogdanova D, Milanov I, Georgiev D. Parkinsonian syndrome as a neurological manifestation of Behçet's disease.  Can J Neurol Sci. 1998;  25(1) 82-85
• 32 Hoffman Snyder C, Mishark K H, Caviness J N, Drazkowski J F, Caselli R J. Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob disease.  Arch Neurol. 2006;  63(5) 766-768
• 33 Golbe L I, Miller D C, Duvoisin R C. Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism.  Mov Disord. 1989;  4(2) 147-152
• 34 Tan J H, Goh B C, Tambyah P A, Wilder-Smith E. Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma.  Parkinsonism Relat Disord. 2005;  11(3) 187-191
• 35 Yu Z, Kryzer T J, Griesmann G E, Kim K, Benarroch E E, Lennon V A. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.  Ann Neurol. 2001;  49(2) 146-154
• 36 Pittock S J, Lucchinetti C F, Lennon V A. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.  Ann Neurol. 2003;  53(5) 580-587
• 37 Dalmau J, Graus F, Villarejo A et al.. Clinical analysis of anti-Ma2-associated encephalitis.  Brain. 2004;  127(Pt 8) 1831-1844
• 38 Tan K M, Lennon V A, Klein C J, Boeve B F, Pittock S J. Clinical spectrum of voltage-gated potassium channel autoimmunity.  Neurology. 2008;  70(20) 1883-1890
• 39 Thomas B, Beal M F. Parkinson's disease.  Hum Mol Genet. 2007;  16 R183-R194
• 40 Lees J A. Secondary Parkinson's syndromes. In: Jankovic J, Tolosa E Parkinson's Disease & Movement Disorders. 5th ed. Philadelphia, PA; Lippincott Williams & Wilkins 2007: 213-224
• 41 Stepens A, Logina I, Liguts V et al.. A parkinsonian syndrome in methcathinone users and the role of manganese.  N Engl J Med. 2008;  358(10) 1009-1017
• 42 Choi I S. Parkinsonism after carbon monoxide poisoning.  Eur Neurol. 2002;  48(1) 30-33
• 43 Dietemann J L, Reimund J M, Diniz R LFC et al.. High signal in the adenohypophysis on T1-weighted images presumably due to manganese deposits in patients on long-term parenteral nutrition.  Neuroradiology. 1998;  40(12) 793-796
• 44 Wenning G K, Kiechl S, Seppi K et al.. Prevalence of movement disorders in men and women aged 50–89 years (Bruneck Study cohort): a population-based study.  Lancet Neurol. 2005;  4(12) 815-820
• 45 Esper C D, Factor S A. Failure of recognition of drug-induced parkinsonism in the elderly.  Mov Disord. 2008;  23(3) 401-404
• 46 Ala A, Walker A P, Ashkan K, Dooley J S, Schilsky M L. Wilson's disease.  Lancet. 2007;  369(9559) 397-408
• 47 Pfeiffer R F. Wilson's disease.  Semin Neurol. 2007;  27(2) 123-132
• 48 Geyer H L, Bressman S B. The diagnosis of dystonia.  Lancet Neurol. 2006;  5(9) 780-790
• 49 Gijtenbeek J M, van den Bent M J, Vecht C J. Cyclosporine neurotoxicity: a review.  J Neurol. 1999;  246(5) 339-346
• 50 Morgan J C, Sethi K D. Drug-induced tremors.  Lancet Neurol. 2005;  4(12) 866-876
• 51 Tarsy D, Simon D K. Dystonia.  N Engl J Med. 2006;  355(8) 818-829
• 52 Németh A H. The genetics of primary dystonias and related disorders.  Brain. 2002;  125 695-721
• 53 Breakefield X O, Blood A J, Li Y, Hallett M, Hanson P I, Standaert D G. The pathophysiological basis of dystonias.  Nat Rev Neurosci. 2008;  9(3) 222-234
• 54 Fahn S, Bressman S B, Marsden C D. Classification of dystonia. In: Fahn S, Marsden CD, Delong M Dystonia 3: Advances in Neurology, Vol. 78. Philadelphia, PA; Lippincott-Raven Publishers 1998: 1-10
• 55 Miyajima H. Aceruloplasminemia. Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=acp Accessed June 15, 2008
• 56 Danek A, Dobson-Stone C, Velayos-Baeza A. The phenotype of chorea-acanthocytosis: a review of 106 patients with VPS13A mutations.  Mov Disord. 2005;  20(12) 1678
• 57 Walker R H, Danek A, Dobson-Stone C et al.. Developments in neuroacanthocytosis: expanding the spectrum of choreatic syndromes.  Mov Disord. 2006;  21(11) 1794-1805
• 58 Patterson M. Niemann-Pick disease Type C. Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=npc Accessed July 20, 2008
• 59 Ekinci B, Apaydin H, Vural M, Ozekmekci S. Two siblings with homocystinuria presenting with dystonia and parkinsonism.  Mov Disord. 2004;  19(8) 962-964
• 60 Cerovac-Cosić N, Petrović I, Klein C, Kostić V. Delayed-onset dystonia due to perinatal asphyxia: a prospective study.  Mov Disord. 2007;  22(16) 2426-2429
• 61 Bhatt M H, Obeso J A, Marsden C D. Time course of postanoxic akinetic-rigid and dystonic syndromes.  Neurology. 1993;  43(2) 314-317
• 62 Barabas G, Tucker S M. Idiopathic hypoparathyroidism and paroxysmal dystonic choreoathetosis.  Ann Neurol. 1988;  24(4) 585
• 63 Tan E K, Chan L L. Movement disorders associated with hyperthyroidism: expanding the phenotype.  Mov Disord. 2006;  21(7) 1054-1057
• 64 Siejka S J, Knezevic W V, Pullan P T. Dystonia and intracerebral calcification: pseudohypoparathyroidism presenting in an eleven-year-old girl.  Aust N Z J Med. 1988;  18(4) 607-609
• 65 Jankovic J, Patten B M. Blepharospasm and autoimmune disease.  Mov Disord. 1987;  2(3) 159-163
• 66 Edwards M J, Trikouli E, Martino D et al.. Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective study.  Neurology. 2004;  63(1) 156-158
• 67 Edwards M J, Dale R C, Church A J, Giovannoni G, Bhatia K P. A dystonic syndrome associated with anti-basal ganglia antibodies.  J Neurol Neurosurg Psychiatry. 2004;  75(6) 914-916
• 68 Rajagopalan N, Humphrey P R, Bucknall R C. Torticollis and blepharospasm in systemic lupus erythematosus.  Mov Disord. 1989;  4(4) 345-348
• 69 Revilla F J, Racette B A, Perlmutter J S. Chorea and jaw-opening dystonia as a manifestation of NeuroBehcet's syndrome.  Mov Disord. 2000;  15(4) 741-744
• 70 Fung V S, Duggins A, Morris J G, Lorentz I T. Progressive myoclonic ataxia associated with celiac disease presenting as unilateral cortical tremor and dystonia.  Mov Disord. 2000;  15(4) 732-734
• 71 Zwecker M, Iancu I, Zeilig G, Ohry A. Camptocormia: a case of possible paraneoplastic aetiology.  Clin Rehabil. 1998;  12(2) 157-160
• 72 Yebenes J G, Cantarero S, Tabernero C, Vazquez A V. Symptomatic dystonias. In: Watts R, Koller W Movement Disorders: Neurologic Principles and Practice. New York, NY; McGraw-Hill 2004: 541-567
• 73 Dressler D, Benecke R. Diagnosis and management of acute movement disorders.  J Neurol. 2005;  252(11) 1299-1306
• 74 Kenney C, Hunter C, Davidson A, Jankovic J. Metoclopramide, an increasingly recognized cause of tardive dyskinesia.  J Clin Pharmacol. 2008;  48(3) 379-384
• 75 Alarcón F, Zijlmans J C, Dueñas G, Cevallos N. Post-stroke movement disorders: report of 56 patients.  J Neurol Neurosurg Psychiatry. 2004;  75(11) 1568-1574
• 76 du Plessis A J, Bellinger D C, Gauvreau K et al.. Neurologic outcome of choreoathetoid encephalopathy after cardiac surgery.  Pediatr Neurol. 2002;  27(1) 9-17
• 77 Nazabal E R, Lopez J M, Perez P A, Del Corral P R. Chorea disclosing deterioration of polycythaemia vera.  Postgrad Med J. 2000;  76(900) 658-659
• 78 Midi I, Dib H, Köseoglu M, Afsar N, Gunal D I. Hemichorea associated with polycythaemia vera.  Neurol Sci. 2006;  27(6) 439-441
• 79 Cardoso F, Vargas A P, Oliveira L D, Guerra A A, Amaral S V. Persistent Sydenham's chorea.  Mov Disord. 1999;  14(5) 805-807
• 80 Chorea, ballism, athetosis: phenomenology and etiology. In: Fahn S, Jankovic J Principles and Practice of Movement Disorders. 1st ed. Philadelphia, PA; Elsevier 2007: 393-407
• 81 Church A J, Cardoso F, Dale R C, Lees A J, Thompson E J, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea.  Neurology. 2002;  59(2) 227-231
• 82 Paz J A, Silva C A, Marques-Dias M J. Randomized double-blind study with prednisone in Sydenham's chorea.  Pediatr Neurol. 2006;  34(4) 264-269
• 83 Teixeira A L, Cardoso F, Maia D P, Cunningham M C. Sydenham's chorea may be a risk factor for drug induced parkinsonism.  J Neurol Neurosurg Psychiatry. 2003;  74(9) 1350-1351
• 84 Sanna G, Bertolaccini M L, Cuadrado M J et al.. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.  J Rheumatol. 2003;  30(5) 985-992
• 85 Miranda M, Cardoso F, Giovannoni G, Church A. Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies.  J Neurol Neurosurg Psychiatry. 2004;  75(2) 327-328
• 86 Vela L, Sfakianakis G N, Heros D, Koller W, Singer C. Chorea and contraceptives: case report with PET study and review of the literature.  Mov Disord. 2004;  19(3) 349-352
• 87 Bordelon Y M, Smith M. Movement disorders in pregnancy.  Semin Neurol. 2007;  27(5) 467-475
• 88 Vernino S, Tuite P, Adler C H et al.. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.  Ann Neurol. 2002;  51(5) 625-630
• 89 Kujawa K A, Niemi V R, Tomasi M A, Mayer N W, Cochran E, Goetz C G. Ballistic-choreic movements as the presenting feature of renal cancer.  Arch Neurol. 2001;  58(7) 1133-1135
• 90 Oh S H, Lee K Y, Im J H, Lee M S. Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI study: a meta-analysis of 53 cases including four present cases.  J Neurol Sci. 2002;  200(1–2) 57-62
• 91 Chang M H, Li J Y, Lee S R, Men C Y. Non-ketotic hyperglycaemic chorea: a SPECT study.  J Neurol Neurosurg Psychiatry. 1996;  60(4) 428-430
• 92 Lai S L, Tseng Y L, Hsu M C, Chen S S. Magnetic resonance imaging and single-photon emission computed tomography changes in hypoglycemia-induced chorea.  Mov Disord. 2004;  19(4) 475-478
• 93 Hayashi R, Hashimoto T, Tako K. Efficacy of propranolol in hyperthyroid-induced chorea: a case report.  Mov Disord. 2003;  18(9) 1073-1076
• 94 Taurin G, Golfier V, Pinel J F et al.. Choreic syndrome due to Hashimoto's encephalopathy.  Mov Disord. 2002;  17(5) 1091-1092
• 95 Isaacs J D, Rakshi J, Baker R, Brooks D J, Warrens A N. Chorea associated with thyroxine replacement therapy.  Mov Disord. 2005;  20(12) 1656-1657
• 96 Lee E J, Park J H, Ihn Y, Kim Y J, Lee S K, Park C S. Acute bilateral basal ganglia lesions in diabetic uraemia: diffusion-weighted MRI.  Neuroradiology. 2007;  49(12) 1009-1013
• 97 Park J H, Kim H J, Kim S M. Acute chorea with bilateral basal ganglia lesions in diabetic uremia.  Can J Neurol Sci. 2007;  34(2) 248-250
• 98 Topakian R, Stieglbauer K, Rotaru J, Haring H P, Aichner F T, Pichler R. Hypocalcemic choreoathetosis and tetany after bisphosphonate treatment.  Mov Disord. 2006;  21(11) 2026-2027
• 99 Janavs J L, Aminoff M J. Dystonia and chorea in acquired systemic disorders.  J Neurol Neurosurg Psychiatry. 1998;  65(4) 436-445
• 100 Cardoso F, Seppi K, Mair K J, Wenning G K, Poewe W. Seminar on choreas.  Lancet Neurol. 2006;  5(7) 589-602